opinion parliamentary committee draft, 20 November 2023
On discharge in respect of the implementation of the budget of the European Monitoring Centre for Drugs and Drug Addiction for the financial year 2022
Document LIBE-PA-756194 · (2023/2157(DEC))
Committee on Civil Liberties, Justice and Home Affairs · Rapporteur: Tomáš Zdechovský
AI:In short
This is the Committee on Civil Liberties, Justice and Home Affairs' draft opinion on discharge for the European Monitoring Centre for Drugs and Drug Addiction's 2022 budget. It asks the Committee on Budgetary Control to include its suggestions in its motion for a resolution. The committee welcomes the Court of Auditors' declaration that the Centre's 2022 transactions were legal and regular, and welcomes the Centre's publications, training, cooperation projects and work with other agencies.
Position. The committee proposes that the Committee on Budgetary Control incorporate its suggestions into its motion for a resolution, welcoming the Court of Auditors' declaration and the Centre's activities, and recalling the link between drug trafficking and organized crime and terrorism.
Key points
- The committee calls on the Committee on Budgetary Control to incorporate its suggestions into its motion for a resolution.
- It welcomes the Court of Auditors' declaration that the Centre's 2022 transactions were legal and regular in all material respects.
- It welcomes the European Drug Report 2022, the Statistical Bulletin 2022 and the EU Early Warning System on new psychoactive substances, run by the Centre for 25 years in 2022.
- It welcomes drug-related training with 609 law enforcement professionals, delivered with CEPOL, and considers it essential to continue raising awareness of prevention and innovative mental-health-based approaches.
- It welcomes progress on the joint EU Drug Markets: In-depth analysis with Europol, work on core supply data with Reitox National Focus Points and Europol, and implementation of tasks under the Multidisciplinary Platform Against Criminal Threats operational action plans on cannabis, cocaine and heroin.
- It recalls that drug trafficking has been identified as a main source of profit and a channel of recruitment of organized crime and terrorism, and highlights the Centre's contribution to a more secure Europe.
- It welcomes the resource page EMCDDA 4 Ukraine, created for professionals working in the drugs field in Europe supporting people displaced from Ukraine.
- It welcomes cooperation with European Neighbourhood Policy partner countries through the EU4MD project, the bilateral project with Georgia EMCDDA4GE, and the establishing of official partnership in the Cooperation Programme between Latin America, the Caribbean and the European Union on Drugs Policies.
- It welcomes the Centre's cooperation with other agencies, its contribution to the JHA agencies' network, and its continuous cooperation with national drugs agencies, third countries and international organizations such as UNODC and the WHO.
Who is affected
- The European Monitoring Centre for Drugs and Drug Addiction: its 2022 budget implementation is the subject of the discharge procedure.
- The Committee on Budgetary Control: asked to incorporate the suggestions into its motion for a resolution.
- Law enforcement professionals and technical cooperation project partners: participated in the Centre's drug-related training.
- People displaced from Ukraine and professionals working in the drugs field in Europe: supported by the EMCDDA 4 Ukraine resource page.
Figures and deadlines
Written by AI from the full text · every figure comes from the text · ¶ opens the paragraph · 25 Sept 2026 · Report a problem
Full text
Suggestions 8 paragraphs
The Committee on Civil Liberties, Justice and Home Affairs calls on the Committee on Budgetary Control, as the committee responsible, to incorporate the following suggestions into its motion for a resolution:
1.Welcomes the fact that the Court of Auditors (the ‘Court’) has declared the transactions underlying the annual accounts of the European Monitoring Centre for Drugs and Drug Addiction (the 'Centre’) for the financial year 2022 to be legal and regular in all material respects;
2.Welcomes the yearly flagship publication, the European Drug Report 2022, the Statistical Bulletin 2022 and the added value of the EU Early Warning System on new psychoactive substances run by the Centre for 25 years in 2022;
3.Welcomes the drug-related training activities with participation of 609 law enforcement professionals from the EU and technical cooperation project partners delivered by the Centre in cooperation with the European Union Agency for Law Enforcement Training (CEPOL); considers it essential to continue raising awareness of the importance of prevention and innovative mental-health-based approach to drugs policies;
4.Welcomes the progress made by the Centre on the joint EU Drug Markets: In-depth analysis, in collaboration with Europol, with modules on specific drugs released throughout 2022 and with planned releases in 2023; welcomes the work in 2022 on improving the quality and availability of core supply data in collaboration with the Reitox National Focus Points and Europol; welcomes the implementation of all of the Centre’s tasks under the Multidisciplinary Platform Against Criminal Threats operational action plans on cannabis, cocaine and heroin; recalls that drug trafficking has been identified as a main source of profit and a channel of recruitment of organized crime and terrorism, and highlights the contribution of the Centre to a more secure Europe;
5.Welcomes the resource page, EMCDDA 4 Ukraine, created for professionals working in the drugs field in Europe supporting people displaced from Ukraine;
6.Welcomes the ongoing cooperation between the Centre and European Neighbourhood Policy partner countries at regional level, through the EU4MD technical assistance project, as well as the ongoing implementation of the bilateral project with Georgia EMCDDA4GE; welcomes the establishing of official partnership in the Cooperation Programme between Latin America, the Caribbean and the European Union on Drugs Policies;
7. Welcomes the Centre’s cooperation with other agencies and its contribution to the JHA agencies’ network; welcomes the Centre’s continuous cooperation with national drugs agencies, third countries and international organizations such as UNODC and the WHO;